Ruthenium Pincer Complexes for Light Activated Toxicity: Lipophilic Groups Enhance Toxicity
Yifei Sun et al, SSRN Electronic Journal CrossRef
Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells
Aycan Asik et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
Ruthenium pincer complexes for light activated toxicity: Lipophilic groups enhance toxicity
Yifei Sun et al, 2023, Journal of Inorganic Biochemistry CrossRef
Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
Vivek Kaushik et al, 2018, Cancers CrossRef
The hidden architects of glioblastoma multiforme: Glioma stem cells
Om S. Sahoo et al, 2024, MedComm – Oncology CrossRef
Effect of salinomycin on EMT and stemness pathways in 5-FU-resistant breast cancer
Divya Sivanesan et al, 2021, Advances in Cancer Biology - Metastasis CrossRef
A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivity
Chaowei Hao et al, 2024, European Journal of Medicinal Chemistry CrossRef
Salinomycin-Loaded Iron Oxide Nanoparticles for Glioblastoma Therapy
Mohammad Norouzi et al, 2020, Nanomaterials CrossRef
Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein
Justin W. Magrath et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
Joshua Alcaniz et al, 2023, Frontiers in Oncology CrossRef
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma
Xudong Liu et al, 2023, Cancers CrossRef
A Yeast Mutant Screen Identifies TORC and Lys63 Polyubiquitination Pathway Genes among Determinants of Sensitivity to the Cancer Stem Cell-Specific Drug Salinomycin
null Donald Rozario et al, 2021, Journal of Analytical Oncology CrossRef